Deloitte’s Technology Fast 500 Award


PORTLAND, Maine, Nov 13, 2013 /PRNewswire/ –Putney, Inc., a rapidly growing pet pharmaceutical company focused on the development and sale of generic prescription medicines for pets, today announced it ranked number 290 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, life sciences, telecommunications and media companies in North America. The company qualified for the recognition as a biotech/pharma company using its proprietary intellectual property in developing FDA approved veterinary generics to drive revenue growth of 304%.

Putney president and CEO, Jean Hoffman, says the ranking as a Technology Fast 500 company recognizes the scientific expertise and marketplace innovation that drives Putney’s commercial success. “Putney has invested millions of dollars in R&D to develop FDA approved generics of expensive branded veterinary drugs. We are the only companion animal health company that is focused entirely on developing and commercializing veterinary generics, to help make pet healthcare more affordable,” says Hoffman. Putney launched two first-to-market FDA approved veterinary generics in 2013, Putney Enrofloxacin Tablets (generic of Baytril™) and Putney Cefpodoxime Proxetil (generic of Simplicef™).

“The 2013 Deloitte Technology Fast 500 companies are exemplary cases of those spurring growth in a tough market through innovation,” said Eric Openshaw, vice chairman, Deloitte LLP and U.S. technology, media and telecommunications leader. “This year’s list is a who’s who of companies behind the most exciting and innovative products and services in the technology space.”

James Atwell, national managing partner of the Emerging Growth Company practice, Deloitte Services LP, continues. “The fastest growing companies in the US are drivers of constant innovation. The companies excelling in these (technology) sectors have a startup mentality that allows them to be nimble and adapt quickly, which is why they consistently lead the list of fast-growing companies each year.”

PUTNEY™ and logo are registered trademarks of Putney, Inc. ©2013 Putney, Inc. Baytril™ is a registered trademark of Bayer Aktiengesellschaft.
Taste Tab™ is a registered trademark of Bayer Healthcare LLC.
Simplicef™ is a registered trademark of PAH P&U LLC.

About Putney

Putney is a pharmaceutical company committed to providing high quality, cost-effective generic medicines for pets. Putney’s reliable supply of affordable drug options empowers veterinarians, allowing them to provide the right medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations. Putney’s ongoing investment in research and development is focused on creating the next generation of generic veterinary products based on inputs from companion animal veterinarians and its industry partners. Learn more at

About Deloitte’s 2013 Technology Fast 500™

Technology Fast 500, conducted by Deloitte LLP, provides a ranking of the fastest growing technology, media, telecommunications, life sciences and clean technology companies both public and private – in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2008 to 2012.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least $50,000 USD or CD, and current-year operating revenues of at least $5 million USD or CD. Additionally, companies must be in business for a minimum of five years, and be headquartered within North America.